Article Details
Retrieved on: 2021-08-16 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The latest transition comes as the San Francisco biotech grapples with the FDA rejection of its AstraZeneca-partnered anemia drug roxadustat.
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here